IGC AMEX
IGC Pharma, Inc.
1W: -2.7%
1M: -7.1%
3M: -2.2%
YTD: -5.5%
1Y: -33.2%
3Y: -23.1%
5Y: -82.0%
$0.27
+0.00 (+1.81%)
Weekly Expected Move ±5.9%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$1M
Revenue
-6.7% YoY
$-7M
Net Income
+8.0% YoY
$-6M
Free Cash Flow
-24.2% YoY
17.4%
Gross Margin
-775.4%
Op. Margin
-757.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-105.2%
ROA-73.0%
ROIC-118.3%
Valuation
P/E-3.3
P/B4.5
EV/EBITDA-4.2
Leverage
Debt/Equity0.15
Current Ratio0.40
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z-16.96
Beneish M-2.10